MedPath

TEVA-MAPROTILINE

TEVA-MAPROTILINE

Discontinued
DIN Number

02158612

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02158612
AIG Number0111022003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AA21 MAPROTILINE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.28
Health Canada Classification

ACTIVE INGREDIENTS (1)

MAPROTILINE HYDROCHLORIDEActive
Strength: 25 MG
Monograph: MAPROTILINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.